Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.

Item
http://www.wikidata.org/entity/Q35534349

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.

Item
http://www.wikidata.org/entity/Q35534349
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@ast
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@en
type
label
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@ast
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@en
prefLabel
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@ast
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Combined treatment of Nimotuzu ...... s of the EGFR mutation status.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932